1. Home
  2. HRMY vs PRGO Comparison

HRMY vs PRGO Comparison

Compare HRMY & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.78

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$15.08

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
PRGO
Founded
2017
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2020
1991

Fundamental Metrics

Financial Performance
Metric
HRMY
PRGO
Price
$36.78
$15.08
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
$49.75
$20.33
AVG Volume (30 Days)
615.1K
2.6M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
7.78%
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$4,281,800,000.00
Revenue This Year
$23.29
N/A
Revenue Next Year
$15.98
N/A
P/E Ratio
$11.58
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$12.17
52 Week High
$40.93
$30.93

Technical Indicators

Market Signals
Indicator
HRMY
PRGO
Relative Strength Index (RSI) 48.42 60.02
Support Level $35.16 $14.66
Resistance Level $37.08 $15.38
Average True Range (ATR) 1.43 0.51
MACD -0.21 0.09
Stochastic Oscillator 43.22 81.19

Price Performance

Historical Comparison
HRMY
PRGO

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: